1-4 of 4
Tiffani Taylor
Close
Sort by
Journal Articles

Safe and Efficient Peripheral Blood Stem Cell Collection in Patients with Sickle Cell Disease Using Plerixafor

Alexis Leonard, MD, Naoya Uchida, MD, David F. Stroncek, MD, Sandhya R. Panch, MDMPH, Kamille West, Eoghan George Molloy, MD, Tom Hughes, Pharm.D., Sara Hauffe, RN, Tiffani Taylor, Courtney D. Fitzhugh, MD, Jane S. Hankins, MD MS, Megan Wilson, MSW, CCRP, Akshay Sharma, MBBS, Shengdar Q. Tsai, PhD, Mitchell J. Weiss, MD, PhD, Matthew Hsieh, MD, John F. Tisdale, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 1964.
https://doi.org/10.1182/blood-2019-126091
Published: 2019
Journal Articles

At least 20% donor myeloid chimerism is necessary to reverse the sickle phenotype after allogeneic HSCT

Brief Report
Courtney D. Fitzhugh, Stefan Cordes, Tiffani Taylor, Wynona Coles, Katherine Roskom, Mary Link, Matthew M. Hsieh, John F. Tisdale
Journal: Blood
Blood (2017) 130 (17): 1946–1948.
https://doi.org/10.1182/blood-2017-03-772392
Published: 2017
Includes: Supplemental data
Journal Articles

At Least 20% Donor Myeloid Chimerism Is Necessary to Reverse the Sickle Phenotype after Allogeneic Hematopoietic Stem Cell Transplantation

Courtney D. Fitzhugh, MD, Matthew M. Hsieh, MD, Stefan Cordes, MD, Tiffani Taylor, PA, Wynona Coles, MPH, Katherine Roskom, RN, John F. Tisdale, MD
Journal: Blood
Blood (2016) 128 (22): 2483.
https://doi.org/10.1182/blood.V128.22.2483.2483
Published: 2016
Journal Articles

Prevalence of Anti-Human Factor VIII Binding IgG Antibodies in Sickle Cell Disease Patients before and after Hematopoietic Stem Cell Transplantation

Jay N Lozier, MD PhD, Eugene Park, BS, Chutima Kumkhaek, PhD, Mary E Link, BSN, Wynona Coles, MPH, Tiffani Taylor, PA, John F. Tisdale, MD, Matthew Hsieh, MD
Journal: Blood
Blood (2016) 128 (22): 3842.
https://doi.org/10.1182/blood.V128.22.3842.3842
Published: 2016